ArticleBlood advances2020

Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia.

Nitin Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.